Press Release
Category Added in a WPeMatico Campaign
-
Business Wire2 days ago
Infinity Natural Resources Publishes Updated Hedge Positions
MORGANTOWN, W. Va.–(BUSINESS WIRE)–Infinity Natural Resources, Inc. (“Infinity” or the “Company”) (NYSE: INR) (INR) today provided an update on its…
Read More » -
Business Wire2 days ago
Gelt Launches AI-Powered Tax Calculator Hub to Quantify the Value of Advanced Tax Strategies Ahead of 2026 Tax Season
New hub delivers fast, dollar-based insights for S Corp elections, PTET, and other high-impact strategies. MIAMI–(BUSINESS WIRE)–Gelt, the AI-native tax…
Read More » -
Viatris to Present at the 44th Annual J.P. Morgan Healthcare Conference
PITTSBURGH, Dec. 17, 2025 /PRNewswire/ — Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the Company will…
Read More » -
Sealed Air Announces Expiration of “Go-Shop” Period
Transaction is Expected to Close in Mid-2026 CHARLOTTE, N.C., Dec. 17, 2025 /PRNewswire/ — Sealed Air Corporation (“Sealed Air” or the…
Read More » -
Protalix Biotherapeutics and Secarna Pharmaceuticals Enter into Collaboration and Option Agreement
Partnership combines Protalix’s rare disease and biologics expertise with Secarna’s AI–powered OligoCreator® platform to jointly develop pharmaceutical candidates for rare…
Read More » -
PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
PADCEV plus Keytruda is the first and only regimen without platinum-based chemotherapy to improve event-free and overall survival when used…
Read More » -
IFS Announces IFS Unleashed and IFS Connect series dates for 2026
New Annual Pass launched IFS Unleashed confirmed for October 12-16, 2026 in Orlando, Fl IFS Connect series of 10 regional…
Read More » -
Business Wire2 days ago
KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Significantly Improved Event-Free Survival, Overall Survival and Pathologic Complete Response Rates for Cisplatin-Eligible Patients with MIBC When Given Before and After Surgery
First and only immunotherapy plus ADC regimen, used perioperatively, to extend survival for cisplatin-eligible patients with MIBC RAHWAY, N.J.–(BUSINESS WIRE)–Merck…
Read More » -
Early Bitcoin Investor Nick Rose Doubles Down on Bitcoin Mining and AI Data Centers
Strategic partnerships target low-cost energy markets in developing economies LOS ANGELES, Dec. 17, 2025 /PRNewswire/ — Orion Compute, founded by early Bitcoin…
Read More » -
Best Email Marketing Platform for Small Business (2026): Mailchimp Ranked #1 for Ease and Results by Expert Consumers
NEW YORK, Dec. 17, 2025 /PRNewswire/ — Expert Consumers has released its latest evaluation of email marketing platforms for small…
Read More »




